| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4761207 | Pathology | 2007 | 5 Pages |
Abstract
bFGF augments hypoxia induced VEGF release mainly through the PI3K pathway and partly depending on HIF-1 activity. Elucidation of this mechanism may provide a new target for anti-angiogenesis in cancer therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Forensic Medicine
Authors
Yong-Hong Shi, Lynne Bingle, Li-Hua Gong, Yu-Xiang Wang, Kevin P. Corke, Wei-Gang Fang,